Literature DB >> 28848819

Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.

Alvar Agustí1, Peter M Calverley2, Marc Decramer3, Robert A Stockley4, Jadwiga A Wedzicha5.   

Abstract

The 2011 recommendations of the Global initiative for chronic Obstructive Lung Disease (GOLD) constituted a major paradigm shift in COPD management since they set 2 major goals for the assessment and management of patients: (1) the reduction of their current level of symptoms (i.e., treat the patient today); and (2) the reduction of their risk of exacerbations (i.e., prevent them tomorrow). Exacerbations are not only an important clinical endpoint in patients with COPD, but they are also a risk factor themselves for additional adverse outcomes since they have been shown to increase the risk for mortality, to accelerate the decline in pulmonary function, and to decrease health status and quality of life. Despite their importance, many unanswered questions related to exacerbations remain. The purpose of this review is to discuss: (1)knowns and unknowns in our current understanding of exacerbations, (2) what known factors increase their risk, and (3) how to best prevent them.

Entities:  

Keywords:  chronic bronchitis; copd; emphysema; exacerbations; inflammation; smoking; therapy

Year:  2014        PMID: 28848819      PMCID: PMC5556862          DOI: 10.15326/jcopdf.1.2.2014.0134

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  128 in total

1.  Chronic obstructive pulmonary disease: a slowly progressive cardiovascular disease masked by its pulmonary effects?

Authors:  Frans H Rutten; Arno W Hoes
Journal:  Eur J Heart Fail       Date:  2012-02-25       Impact factor: 15.534

Review 2.  Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?

Authors:  Juan José Soler-Cataluña; Roberto Rodriguez-Roisin
Journal:  COPD       Date:  2010-08       Impact factor: 2.409

Review 3.  Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies.

Authors:  Yoon K Loke; Rodrigo Cavallazzi; Sonal Singh
Journal:  Thorax       Date:  2011-05-20       Impact factor: 9.139

4.  Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study.

Authors:  Elif Küpeli; Gaye Ulubay; Sevinc Sarinc Ulasli; Tugce Sahin; Zeynep Erayman; Alptekin Gürsoy
Journal:  Endocrine       Date:  2010-06-09       Impact factor: 3.633

5.  Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

Authors:  Peter M A Calverley; Klaus F Rabe; Udo-Michael Goehring; Søren Kristiansen; Leonardo M Fabbri; Fernando J Martinez
Journal:  Lancet       Date:  2009-08-29       Impact factor: 79.321

6.  Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T A R Seemungal; A Bhowmik; J A Wedzicha
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

Review 7.  COPD exacerbations: definitions and classifications.

Authors:  S Burge; J A Wedzicha
Journal:  Eur Respir J Suppl       Date:  2003-06

8.  Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD.

Authors:  David A McAllister; John D Maclay; Nicholas L Mills; Andrew Leitch; Philip Reid; Ross Carruthers; Jennifer O'Connor; Lawrence McAlpine; George Chalmers; David E Newby; Elaine Clark; Peter W Macfarlane; William Macnee
Journal:  Eur Respir J       Date:  2012-02-09       Impact factor: 16.671

9.  Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease.

Authors:  Paul W Jones; Stephen I Rennard; Alvar Agusti; Pascal Chanez; Helgo Magnussen; Leonardo Fabbri; James F Donohue; Eric D Bateman; Nicholas J Gross; Rosa Lamarca; Cynthia Caracta; Esther Garcia Gil
Journal:  Respir Res       Date:  2011-04-26

10.  The combination of tiotropium and budesonide in the treatment of chronic obstructive pulmonary disease.

Authors:  Sang-Won Um; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Young-Soo Shim
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

View more
  13 in total

1.  The View of the Turkish Thoracic Society on the Report of the GOLD 2017 Global Strategy for the Diagnosis, Management, and Prevention of COPD.

Authors:  Nurdan Köktürk; Alev Gürgün; Elif Şen; Ali Kocabaş; Mehmet Polatlı; Sibel Atış Naycı; Lütfi Çöplü; Emel Tellioğlu; Funda Elmas; Ertürk Erdinç
Journal:  Turk Thorac J       Date:  2017-04-01

2.  Giving Voice to People - Experiences During Mild to Moderate Acute Exacerbations of COPD.

Authors:  Ana Machado; Sara Almeida; Chris Burtin; Alda Marques
Journal:  Chronic Obstr Pulm Dis       Date:  2022-07-29

3.  The European COPD audit : Adherence to guidelines, readmission risk and hospital care for acute exacerbations in Austria.

Authors:  Robab Breyer-Kohansal; Sylvia Hartl; Marie-Kathrin Breyer; Andrea Schrott; Michael Studnicka; Daniel Neunhäuserer; Gerhard Fülöp; Otto Chris Burghuber
Journal:  Wien Klin Wochenschr       Date:  2019-01-28       Impact factor: 1.704

4.  Predicting Hospitalization Due to COPD Exacerbations in Swedish Primary Care Patients Using Machine Learning - Based on the ARCTIC Study.

Authors:  Björn Ställberg; Karin Lisspers; Kjell Larsson; Christer Janson; Mario Müller; Mateusz Łuczko; Bine Kjøller Bjerregaard; Gerald Bacher; Björn Holzhauer; Pankaj Goyal; Gunnar Johansson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-16

5.  Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.

Authors:  Xuehua Ke; Jessica Marvel; Tzy-Chyi Yu; Debra Wertz; Caroline Geremakis; Liya Wang; Judith J Stephenson; David M Mannino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-07-27

6.  Physiological predictors Of peak inspiRatory flow using Observed lung function resultS (POROS): evaluation at discharge among patients hospitalized for a COPD exacerbation.

Authors:  David B Price; Sen Yang; Simon Wan Yau Ming; Antony Hardjojo; Claudia Cabrera; Andriana I Papaioannou; Stelios Loukides; Vicky Kritikos; Sinthia Z Bosnic-Anticevich; Victoria Carter; Paul M Dorinsky
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-12-13

Review 7.  Treatable traits in acute exacerbations of chronic airway diseases.

Authors:  Vanessa M McDonald; Christian R Osadnik; Peter G Gibson
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

Review 8.  Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Ayah Shakshuki; Remigius U Agu
Journal:  Pulm Ther       Date:  2017-06-27

9.  Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus.

Authors:  Raju Bishwakarma; Wei Zhang; Yu-Li Lin; Yong-Fang Kuo; Victor J Cardenas; Gulshan Sharma
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-03-05

10.  Oscillococcinum® for upper respiratory tract infections and exacerbations in COPD: an observational, prospective study (OXITUNIS).

Authors:  Hichem Aouina; Anis Bamri; Aurélien Vesin; Karine Danno; Eléonore Aubry; Cécile Faure; Naoual Boujedaini
Journal:  Drugs Context       Date:  2021-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.